SG11201706165RA - Composition for treating inflammatory disease induced by hyperimmune response - Google Patents
Composition for treating inflammatory disease induced by hyperimmune responseInfo
- Publication number
- SG11201706165RA SG11201706165RA SG11201706165RA SG11201706165RA SG11201706165RA SG 11201706165R A SG11201706165R A SG 11201706165RA SG 11201706165R A SG11201706165R A SG 11201706165RA SG 11201706165R A SG11201706165R A SG 11201706165RA SG 11201706165R A SG11201706165R A SG 11201706165RA
- Authority
- SG
- Singapore
- Prior art keywords
- composition
- inflammatory disease
- treating inflammatory
- disease induced
- hyperimmune response
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562112718P | 2015-02-06 | 2015-02-06 | |
| PCT/KR2016/001310 WO2016126139A1 (en) | 2015-02-06 | 2016-02-05 | Composition for treating inflammatory diseases caused by hyper-immune responses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201706165RA true SG11201706165RA (en) | 2017-09-28 |
Family
ID=56564381
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201706165RA SG11201706165RA (en) | 2015-02-06 | 2016-02-05 | Composition for treating inflammatory disease induced by hyperimmune response |
| SG10202106872WA SG10202106872WA (en) | 2015-02-06 | 2016-02-05 | Composition for treating inflammatory disease induced by hyperimmune response |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10202106872WA SG10202106872WA (en) | 2015-02-06 | 2016-02-05 | Composition for treating inflammatory disease induced by hyperimmune response |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11191787B2 (en) |
| EP (1) | EP3254685B1 (en) |
| JP (1) | JP6475847B2 (en) |
| KR (1) | KR101986774B1 (en) |
| CN (1) | CN107405363A (en) |
| AU (1) | AU2016216223B2 (en) |
| CA (1) | CA2974941C (en) |
| SG (2) | SG11201706165RA (en) |
| WO (1) | WO2016126139A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7452925B2 (en) * | 2017-06-30 | 2024-03-19 | コーロン ライフ サイエンス インコーポレイテッド | Pharmaceutical composition for the prevention or treatment of osteoarthritis |
| CN111033258B (en) * | 2017-06-30 | 2023-09-05 | 可隆生命科学株式会社 | Methods for evaluating the effectiveness of cytotherapeutic products |
| JP7433539B2 (en) | 2021-07-15 | 2024-02-19 | 三菱電機株式会社 | air conditioner |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6413511B1 (en) * | 1990-12-20 | 2002-07-02 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Cartilage alterations by administering to joints chondrocytes comprising a heterologous polynucleotide |
| JP4033400B2 (en) | 2002-03-12 | 2008-01-16 | ティシュージーン，インク | Cartilage regeneration using chondrocytes and TGF-β |
| US7005127B2 (en) * | 2002-03-29 | 2006-02-28 | Tissuegene, Inc. | Mixed-cell gene therapy |
| US8299046B2 (en) * | 2006-11-17 | 2012-10-30 | Trustees Of Dartmouth College | Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth |
| KR20090069013A (en) | 2007-12-24 | 2009-06-29 | 동국대학교 산학협력단 | Chondrogenesis of bone marrow mesenchymal stem cells |
| US20120201791A1 (en) * | 2009-10-15 | 2012-08-09 | Tai June Yoo | Methods of treating diseases or conditions using mesenchymal stem cells |
| KR101301262B1 (en) * | 2009-10-23 | 2013-08-27 | 가톨릭대학교 산학협력단 | Mesenchymal stem cell introduced with a nucleotide sequence encoding TGFβ and use thereof |
-
2016
- 2016-02-05 JP JP2017538300A patent/JP6475847B2/en active Active
- 2016-02-05 CN CN201680008586.3A patent/CN107405363A/en active Pending
- 2016-02-05 US US15/547,566 patent/US11191787B2/en active Active
- 2016-02-05 SG SG11201706165RA patent/SG11201706165RA/en unknown
- 2016-02-05 AU AU2016216223A patent/AU2016216223B2/en active Active
- 2016-02-05 EP EP16746880.0A patent/EP3254685B1/en active Active
- 2016-02-05 SG SG10202106872WA patent/SG10202106872WA/en unknown
- 2016-02-05 WO PCT/KR2016/001310 patent/WO2016126139A1/en active Application Filing
- 2016-02-05 KR KR1020177020973A patent/KR101986774B1/en active IP Right Grant
- 2016-02-05 CA CA2974941A patent/CA2974941C/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018505873A (en) | 2018-03-01 |
| CN107405363A (en) | 2017-11-28 |
| CA2974941A1 (en) | 2016-08-11 |
| US11191787B2 (en) | 2021-12-07 |
| SG10202106872WA (en) | 2021-08-30 |
| EP3254685A4 (en) | 2018-09-19 |
| KR20170104498A (en) | 2017-09-15 |
| JP6475847B2 (en) | 2019-02-27 |
| AU2016216223B2 (en) | 2018-08-30 |
| WO2016126139A1 (en) | 2016-08-11 |
| EP3254685A1 (en) | 2017-12-13 |
| KR101986774B1 (en) | 2019-06-07 |
| US20180264045A1 (en) | 2018-09-20 |
| EP3254685B1 (en) | 2022-04-20 |
| AU2016216223A1 (en) | 2017-08-03 |
| CA2974941C (en) | 2021-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL301117I2 (en) | trastuzumab deluxtecan | |
| SG11201705093UA (en) | Composition for treating il-6-related diseases | |
| IL251508A0 (en) | Anti-tnf compounds | |
| GB201506871D0 (en) | Novel compounds | |
| GB201506872D0 (en) | Novel compounds | |
| GB201501462D0 (en) | Novel compounds | |
| HK1257665A1 (en) | Novel compounds for treating mitochondrial disease | |
| IL278247B (en) | Mct4 inhibitors for treating disease | |
| HK1245804A1 (en) | Anti-csf1r antibodies for treating pvns | |
| HK1253238A1 (en) | Gls1 inhibitors for treating disease | |
| HK1255871A1 (en) | Cerdulatinib for treating myeloma | |
| SI3390450T1 (en) | Anti-cd28 humanized antibodies formulated for administration to humans | |
| GB201504565D0 (en) | Novel compounds | |
| GB201721287D0 (en) | Treatment for inflammatory disease | |
| HK1248133A1 (en) | Methods for treating neuroblastoma | |
| ZA201707090B (en) | Novel pyridinium compounds | |
| SG11201705828SA (en) | Photocurable composition | |
| FR3038312B1 (en) | PROCESS FOR THE PREPARATION OF POLYOLS | |
| SG10202106872WA (en) | Composition for treating inflammatory disease induced by hyperimmune response | |
| GB201502675D0 (en) | Novel compounds | |
| SI3286198T1 (en) | Compounds for treating pruritic conditions | |
| GB201420348D0 (en) | Compounds for treating neurodegenerative diseases | |
| ZA201704724B (en) | Peptide for treating inflammatory diseases | |
| GB201509756D0 (en) | D-N-A-cure for every disease | |
| GB201511842D0 (en) | Novel compounds |